These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7427411)

  • 1. Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.
    Weisman Y; Eisenberg Z; Leib L; Harell A; Shasha SM; Edelstein S
    Br Med J; 1980 Sep; 281(6242):712-3. PubMed ID: 7427411
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D metabolites and their relationship to azotaemic osteodystrophy.
    Mason RS; Lissner D; Wilkinson M; Posen S
    Clin Endocrinol (Oxf); 1980 Oct; 13(4):375-85. PubMed ID: 7438480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 24,25 dihydroxycalciferol: assay in non-anephric patients on chronic haemodialysis and assessment of its possible pathophysiological role in renal osteodystrophy.
    Lambrey G; Nguyen TM; Fournier A; Sebert JL; Kassouf J; de Fremont JF; Marie P; Meunier P; Caillens C; Gueris J; Garabedian M; Balsan S
    Proc Eur Dial Transplant Assoc; 1980; 17():548-56. PubMed ID: 6972530
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma 1,25(OH)2 vitamin D measured by radioimmunoassay and cytosol radioreceptor assay in normal subjects and patients with primary hyperparathyroidism and renal failure.
    Peacock M; Taylor GA; Brown W
    Clin Chim Acta; 1980 Feb; 101(1):93-101. PubMed ID: 7357741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of vitamin D metabolites in renal diseases.
    Ogura Y; Kawaguchi Y; Sakai S; Yamamoto M; Kimura Y; Oda Y; Imamura N; Tsukui I
    Contrib Nephrol; 1980; 22():18-27. PubMed ID: 6995016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-25-hydroxycholecalciferol and renal osteodystrophy.
    Nielsen HE; Melsen F; Lund B; Sorensen OH; Christensen MS
    Lancet; 1977 Apr; 1(8014):754-5. PubMed ID: 66549
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum 1,25-dihydroxycholecalciferol in anephric, haemodialyzed and kidney-transplanted patients. Effect of vitamin D3 supplement.
    Lund B; Clausen E; Friedberg M; Lund B; Moszkowicz M; Nielsen SP; Sørensen OH
    Nephron; 1980; 25(1):30-3. PubMed ID: 6243405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxycholecalciferol in uremia.
    Offermann G; von Herrath D; Schaefer K
    Nephron; 1974; 13(4):269-77. PubMed ID: 4608520
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum concentrations of metabolites of vitamin D in patients with chronic renal failure (CRF). Consequences for the treatment with 1-alpha-hydroxy-derivatives.
    Juttmann JR; Buurman CJ; De Kam E; Visser TJ; Birkenhäger JC
    Clin Endocrinol (Oxf); 1981 Mar; 14(3):225-36. PubMed ID: 6973423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay of 24R,25-dihydroxycholecalciferol in human serum.
    Taylor CM
    Methods Enzymol; 1980; 67():414-24. PubMed ID: 6966028
    [No Abstract]   [Full Text] [Related]  

  • 12. 1,25-Dihydroxycholecalciferol in human serum and its relationship with other metabolites of vitamin D-3.
    Taylor CM; Hann J; St John J; Wallace JE; Mawer EB
    Clin Chim Acta; 1979 Aug; 96(1-2):1-8. PubMed ID: 225061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioassay of 1,25-dihydroxyvitamin D in human plasma purified by partition, alkaline extraction, and high-pressure chromatography.
    Stern PH; Phillips TE; Mavreas T
    Anal Biochem; 1980 Feb; 102(1):22-30. PubMed ID: 7356156
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical implications of measurements of circulating vitamin D metabolites.
    Mawer EB
    Clin Endocrinol Metab; 1980 Mar; 9(1):63-79. PubMed ID: 6998611
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteopenia during long-term haemodialysis: response to vitamin D3 analogues.
    Muirhead N; Adami S; Fraser RA; Catto GR; Edward N; O'Riordan JL
    Proc Eur Dial Transplant Assoc; 1981; 18():567-72. PubMed ID: 6895786
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application.
    Tartarotti D; Adami S; Galvanini G; Dorizzi R; Piemonte G; Lo Cascio V
    J Endocrinol Invest; 1984 Dec; 7(6):545-50. PubMed ID: 6335715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on abnormalities of calcium, vitamin D and bone metabolism in patients on maintenance hemodialysis (author's transl)].
    Kitoh C
    Nihon Jinzo Gakkai Shi; 1979 May; 21(5):503-18. PubMed ID: 529620
    [No Abstract]   [Full Text] [Related]  

  • 18. Advances in vitamin D metabolism as they pertain to chronic renal disease.
    Coburn JW; Hartenbower DL; Brickman AS
    Am J Clin Nutr; 1976 Nov; 29(11):1283-99. PubMed ID: 187055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How important is phosphate in the pathogenesis of renal osteodystrophy?
    Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
    Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
    [No Abstract]   [Full Text] [Related]  

  • 20. Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy.
    Weisman Y; Fattal A; Eisenberg Z; Harel S; Spirer Z; Harell A
    Br Med J; 1979 Sep; 2(6189):521-3. PubMed ID: 497670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.